Search

Displaying results 9171 - 9180 of 10000 in total
  1. Drug

    Glesatinib

    go.drugbank.com/drugs/DB06302
    Investigational

  2. Drug

    Onalespib

    go.drugbank.com/drugs/DB06306
    Investigational

  3. Drug

    Avasimibe

    go.drugbank.com/drugs/DB06442
    Experimental

  4. Drug

    Levovirin

    go.drugbank.com/drugs/DB06523
    Experimental

  5. Drug

    TD101

    go.drugbank.com/drugs/DB06596
    Investigational

    TD101, a small interfering RNA (siRNA) designed for the treatment of pachyonychia congenita

  6. Drug

    Anamorelin

    go.drugbank.com/drugs/DB06645
    Investigational

  7. Drug

    Neladalkib

    go.drugbank.com/drugs/DB21712
    Investigational

    The usage of the INN stem '-alkib' in the name indicates that Neladalkib is a ALK (anaplastic lymphoma kinase) inhibitor. … Neladalkib is under investigation in clinical trial NCT06765109 (Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC).

    Synonyms: an orally bioavailable ALK inhibitor (a macrocyclic compound containing nitrogen heterocycles)
  8. Drug

    Sirukumab

    go.drugbank.com/drugs/DB11803
    Investigational

    Sirukumab has been used in trials studying the treatment and basic science of Giant Cell Arteritis and Arthritis, Rheumatoid.

  9. Drug

    AZD-5672

    go.drugbank.com/drugs/DB11804
    Investigational

    Azd5672 has been used in trials studying the basic science and treatment of Pharmacokinetics, Renal Impairment, and Rheumatoid Arthritis.

  10. Drug

    Cilengitide

    go.drugbank.com/drugs/DB11890
    Investigational

    Cilengitide has been used in trials studying the treatment of Sarcoma, Gliomas, Lymphoma, Leukemia, and Lung Cancer, among others.